Association between dose reduction and duration of therapy in patients receiving ibrutinib or acalabrutinib for chronic lymphocytic leukemia: A medical chart review study Meeting Abstract
| Authors: | Shadman, M.; Roeker, L.; Pinilla-Ibarz, J.; Srivastava, B.; Karve, S.; Krigsfeld, G. S.; Franceschini, E.; Saifan, C.; Karanth, S.; Goyal, R. K.; Rombi, J.; Stephens, D. M. |
| Abstract Title: | Association between dose reduction and duration of therapy in patients receiving ibrutinib or acalabrutinib for chronic lymphocytic leukemia: A medical chart review study |
| Meeting Title: | 66th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 144 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2024 Dec 7-10 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2024-11-05 |
| Start Page: | 3742 |
| Language: | English |
| ACCESSION: | WOS:001413016800010 |
| DOI: | 10.1182/blood-2024-205456 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
